MedPath

Novartis Pharmaceutical Manufacturing GmbH

🇦🇹Austria
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

SFDA:5

Drug Approvals

Hyrimoz

Approval Date
Jul 18, 2025
SFDA

SANDOSTATIN LAR 30MG VIAL

Approval Date
Jul 18, 2025
SFDA

SANDOSTATIN LAR 20MG VIAL

Approval Date
Jul 18, 2025
SFDA

OMNITROPE 6.7 MG/ML Solution for injection in cartridge

Approval Date
Jul 18, 2025
SFDA

OMNITROPE 3.3 MG/ML Solution for injection in cartridge

Approval Date
Jul 18, 2025
SFDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.